Zobrazeno 1 - 10
of 289
pro vyhledávání: '"Parvez Mulani"'
Autor:
Remo Panaccione, Edward V Loftus, David Binion, Kevin McHugh, Shamsul Alam, Naijun Chen, Benoît Guérette, Parvez Mulani, Jingdong Chao
Publikováno v:
Canadian Journal of Gastroenterology, Vol 25, Iss 8, Pp 419-425 (2011)
OBJECTIVE: To evaluate open-label adalimumab therapy for clinical effectiveness, fistula healing, patient-reported outcomes and safety in Canadian patients with moderate to severe Crohn’s disease (CD) who were either naive to or previously exposed
Externí odkaz:
https://doaj.org/article/8fc99cce04214177a1efc118cfa7fc8f
Autor:
David G Binion, Edouard Louis, Bas Oldenburg, Parvez Mulani, Arielle G Bensimon, Mei Yang, Jingdong Chao
Publikováno v:
Canadian Journal of Gastroenterology, Vol 25, Iss 9, Pp 492-496 (2011)
OBJECTIVE: To assess the effect of adalimumab on work productivity and indirect costs in patients with Crohn’s disease (CD) using a meta-analysis of clinical trials.
Externí odkaz:
https://doaj.org/article/5f147c650ec14007b6fa67fdc98ff5df
Autor:
Murali Sundaram, Martin M. Okun, A. Brett Hauber, Parvez Mulani, F. Reed Johnson, Alexa B. Kimball, Yanjun Bao, Jui-Chen Yang, Teresa L. Kauf
Publikováno v:
Journal of Dermatological Treatment. 26:507-513
Previous studies suggest that efficacy is more important than side-effect risks to psoriasis patients. However, those studies did not consider potentially fatal risks of biologic treatments.To quantify the risks patients are willing to accept for imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2de6d676c698c82ce8bc0febeed5ecd
https://doi.org/10.3109/09546634.2015.1034071
https://doi.org/10.3109/09546634.2015.1034071
Publikováno v:
Annals of the Rheumatic Diseases
BackgroundThis study assessed the impact of simultaneous achievement of clinical, functional and structural efficacy, herein referred to as comprehensive disease control (CDC), on short-term and long-term work-related outcomes, health-related quality
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d46f777fdbd651507fe2d0f1f9f1c0d
http://europepmc.org/articles/PMC4680119
http://europepmc.org/articles/PMC4680119
Autor:
C. Leonardi, Yihua Gu, Martin M. Okun, Ulrich Mrowietz, Jeffrey J. Crowley, Parvez Mulani, Y. Bao, Jeffrey M. Sobell
Publikováno v:
British Journal of Dermatology. 167:658-667
Summary Background The clinical utility of increasing to weekly adalimumab therapy in patients with psoriasis with inadequate response to every other week (eow) dosing is unknown. Objectives (i) To determine the effectiveness of escalating adalimumab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa5f77900dbece2edd82a23fd2f986ec
https://doi.org/10.1111/j.1365-2133.2012.11041.x
https://doi.org/10.1111/j.1365-2133.2012.11041.x
Autor:
Arijit Ganguli, Eric Q. Wu, Yifei Liu, Chun-Po Steve Fan, Arielle G. Bensimon, Parvez Mulani, Mei Yang, Yanjun Bao, Mary Cifaldi
Publikováno v:
Advances in Therapy. 29:620-634
Biologic therapies have demonstrated efficacy and safety in several chronic systemic disorders. The authors indirectly compared response rates and costs per responder associated with biologic treatments for moderate-to-severe Crohn's disease (CD), ps
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3902b8f53a8434dccfbfcb650bb3dd83
https://doi.org/10.1007/s12325-012-0035-7
https://doi.org/10.1007/s12325-012-0035-7
Autor:
Parvez Mulani, Arielle G. Bensimon, David T. Rubin, Andrew P. Yu, Subrata Ghosh, Jingdong Chao, Paul F. Pollack
Publikováno v:
Inflammatory Bowel Diseases. 18:818-825
Background: Nutritional deficiencies and anemia are common in Crohn's disease (CD). Methods: We evaluated the effect of adalimumab on changes in laboratory values using data from CHARM, in which patients were randomized to adalimumab 40 mg every othe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a84e489ca5296305753cdc393a4c80e7
https://doi.org/10.1002/ibd.21836
https://doi.org/10.1002/ibd.21836
Autor:
Jingdong Chao, Mei Yang, Parvez Mulani, Eric Q. Wu, Edward V. Loftus, Andrew P. Yu, Annie Guerin
Publikováno v:
American Journal of Gastroenterology. 106:1670-1677
Crohn's disease (CD) is associated with substantial psychosocial burden and increased risks for mental health disorders. This retrospective cohort study compared the risks of developing anxiety disorders and depression and incidences of psychotropic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40c12f92dfad0423742e27de6736d34f
https://doi.org/10.1038/ajg.2011.142
https://doi.org/10.1038/ajg.2011.142
Autor:
Edouard Louis, Jingdong Chao, David G. Binion, Bas Oldenburg, Mei Yang, Arielle G. Bensimon, Parvez Mulani
Publikováno v:
Canadian Journal of Gastroenterology, Vol 25, Iss 9, Pp 492-496 (2011)
OBJECTIVE: To assess the effect of adalimumab on work productivity and indirect costs in patients with Crohn’s disease (CD) using a meta-analysis of clinical trials.METHODS: Study-level results were pooled from all clinical trials of adalimumab for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a992b9967ff5e7cdc0b8d56c5b83fefb
https://doi.org/10.1155/2011/938194
https://doi.org/10.1155/2011/938194
Autor:
Anne M. Robinson, Paul F. Pollack, Scott E. Plevy, Jean-Frederic Colombel, Jingdong Chao, William J. Sandborn, Parvez Mulani, Stefan Schreiber
Publikováno v:
Inflammatory Bowel Diseases. 17:141-151
Background: Data from CHARM, a 56-week, randomized controlled trial of adalimumab for patients with moderately to severely active Crohn's disease (CD), were used to evaluate outcomes of adalimumab dosage adjustment. Methods: Patients randomized to bl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94c355354053b58eab963c78a2156986
https://doi.org/10.1002/ibd.21328
https://doi.org/10.1002/ibd.21328